Results 111 to 120 of about 1,440 (152)
Some of the next articles are maybe not open access.
Tinidazole for bacterial vaginosis
Expert Review of Anti-infective Therapy, 2007Tinidazole has been used for bacterial vaginosis (BV) outside the USA for almost four decades. Tinidazole has recently been resurrected and FDA approved for trichomoniasis and BV in the USA and is being restudied as an alternative to metronidazole for BV.
Michael D, Nailor, Jack D, Sobel
openaire +2 more sources
Treatment of Giardiasis with Tinidazole
The American Journal of Tropical Medicine and Hygiene, 1978Fifty-five patients, 51 males and 4 females heavily infected with Giardia lamblia were treated with a single 2 g dose of tinidazole (four tablets); 53 were cured. Of 20 other infected patients kept under the same conditions and given four placebo tablets, 18 continued to pass cysts or trophozoites in the stools during the whole 3- to 4-wk follow-up ...
N A, Masry, Z, Farid, W F, Miner
openaire +2 more sources
Severe toxic reaction to tinidazole
European Journal of Clinical Pharmacology, 1983A physician aged 44 years participated as a volunteer in pharmacokinetic studies with tinidazole (FASIGYN, Pfizer). He received 1600 mg of the drug as an intravenous infusion over 80 min. Shortly afterwards, he fainted and was unconscious for about 10 s. The attack was followed by low blood pressure, nausea and tiredness for several h.
S, Aase +6 more
openaire +2 more sources
Tinidazole: A nitroimidazole antiprotozoal agent
Clinical Therapeutics, 2005Tinidazole, a structural analogue of metrondazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability. It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver ...
Horatio B, Fung, Thien-Ly, Doan
openaire +2 more sources
Drug and Therapeutics Bulletin, 1983
Tinidazole (Fasigyn - Pfizer) is a new antibacterial/antiprotozoal drug whose spectrum is identical to that of metronidazole but for which the manufacturer claims pharmacokinetic advantages.
openaire +1 more source
Tinidazole (Fasigyn - Pfizer) is a new antibacterial/antiprotozoal drug whose spectrum is identical to that of metronidazole but for which the manufacturer claims pharmacokinetic advantages.
openaire +1 more source
[Dynamic release of tinidazole from the degradable PLLA-tinidazole blend gel].
Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2015To determine the dynamic release of tinidazole from the degradable poly-lactic acid (PLLA)-tinidazole blend gel (a periodontal local drug delivery) by high-performance liquid chromatography (HPLC) in vitro and to observe the polylactic acid (as a vector of tinidazole) how to affect the release of tinidazole.HPLC analysis was conducted.
Juan, Liu +5 more
openaire +1 more source